Instadose Pharma Net Tangible Assets

Instadose Pharma (INSD) currently reports a net tangible assets of $36M as of February 2022. That compares with $-16K in the prior-year period — up 225028.7% year over year. Use the charts on this page to explore Instadose Pharma's net tangible assets history and peer comparisons.

Instadose Pharma's net tangible assets increased from $-16K to $36M — a 225028.7% year-over-year increase (period ending February 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Instadose Pharma reported $36M in net tangible assets as of February 2022. That compares with $-16K in the prior-year period — up 225028.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $36M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Instadose Pharma, and consider following INSD for alerts when major investors trade the stock.